GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Asset Turnover

Ovation Science (XCNQ:OVAT) Asset Turnover : 0.52 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Ovation Science's Revenue for the three months ended in Mar. 2024 was C$0.04 Mil. Ovation Science's Total Assets for the quarter that ended in Mar. 2024 was C$0.08 Mil. Therefore, Ovation Science's Asset Turnover for the quarter that ended in Mar. 2024 was 0.52.

Asset Turnover is linked to ROE % through Du Pont Formula. Ovation Science's annualized ROE % for the quarter that ended in Mar. 2024 was 99.09%. It is also linked to ROA % through Du Pont Formula. Ovation Science's annualized ROA % for the quarter that ended in Mar. 2024 was -908.39%.


Ovation Science Asset Turnover Historical Data

The historical data trend for Ovation Science's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Asset Turnover Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial 0.13 0.30 0.11 0.32 0.68

Ovation Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.02 0.03 0.15 0.52

Competitive Comparison of Ovation Science's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Ovation Science's Asset Turnover falls into.



Ovation Science Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Ovation Science's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.062/( (0.105+0.077)/ 2 )
=0.062/0.091
=0.68

Ovation Science's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0.04/( (0.077+0.078)/ 2 )
=0.04/0.0775
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Ovation Science  (XCNQ:OVAT) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Ovation Science's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-0.704/-0.7105
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.704 / 0.16)*(0.16 / 0.0775)*(0.0775/ -0.7105)
=Net Margin %*Asset Turnover*Equity Multiplier
=-440 %*2.0645*-0.1091
=ROA %*Equity Multiplier
=-908.39 %*-0.1091
=99.09 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Ovation Science's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-0.704/0.0775
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.704 / 0.16)*(0.16 / 0.0775)
=Net Margin %*Asset Turnover
=-440 %*2.0645
=-908.39 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Ovation Science Asset Turnover Related Terms

Thank you for viewing the detailed overview of Ovation Science's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovation Science (XCNQ:OVAT) Business Description

Traded in Other Exchanges
Address
625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6
Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.
Executives
David K. Ryan Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines